Borgies P, Ferrant A, Delannoy A, Van den Berghe H, Michaux J L
Department of Haematology, Cliniques Universitaires St-Luc, Brussels, Belgium.
Bone Marrow Transplant. 1989 Jan;4(1):127-8.
We describe a patient with chronic granulocytic leukaemia (CGL) who relapsed after allogeneic bone marrow transplantation (BMT). Interferon alpha 2b (IFN alpha 2b) induced and maintained a complete remission. IFN alpha 2b led to full restoration of donor bone marrow. This case provides evidence to support a trial of IFN alpha in patients with relapsing CGL after BMT.
我们描述了一名慢性粒细胞白血病(CGL)患者,该患者在异基因骨髓移植(BMT)后复发。α2b干扰素(IFNα2b)诱导并维持了完全缓解。IFNα2b导致供体骨髓完全恢复。该病例为支持对BMT后复发的CGL患者进行IFNα试验提供了证据。